Skip to main content

Advertisement

Log in

Spine Bone Texture Assessed by Trabecular Bone Score (TBS) to Evaluate Bone Health in Thalassemia Major

  • Original Research
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Abstract

Due to the increasing survival of thalassemic patients, osteopathy is a mounting clinical problem. Low bone mass alone cannot account for the high fracture risk described; impaired bone quality has been speculated but so far it cannot be demonstrated noninvasively. We studied bone quality in thalassemia major using trabecular bone score (TBS), a novel texture measurement extracted from spine dual-energy X-ray absorptiometry (DXA), proposed in postmenopausal and secondary osteoporosis as an indirect index of microarchitecture. TBS was evaluated in 124 adult thalassemics (age range 19–56 years), followed-up with optimal transfusional and therapeutical regimens, and in 65 non-thalassemic patients (22–52 years) undergoing DXA for different bone diseases. TBS was lower in thalassemic patients (1.04 ± 0.12 [range 0.80–1.30]) versus controls (1.34 ± 0.11 [1.06–1.52]) (p < 0.001), and correlated with BMD. TBS and BMD values correlated with age, indicating that thalassemia negatively affects both bone quality and quantity, especially as the patient gets older. TBS was 1.02 ± 0.11 [0.80–1.28] in the osteoporotic thalassemic patients, 1.08 ± 0.12 [0.82–1.30] in the osteopenic ones and 1.15 ± 0.10 [0.96–1.26] in those with normal BMD. No gender differences were found (males: 1.02 ± 0.13 [0.80–1.30], females 1.05 ± 0.11 [0.80–1.30]), nor between patients with and without endocrine–metabolic disorders affecting bone metabolism. Our findings from a large population with thalassemia major show that TBS is a valuable tool to assess noninvasively bone quality, and it may be related to fragility fracture risk in thalassemic osteopathy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Chatterjee R, Shah FT, Davis BA, Byers M, Sooranna D, Bajoria R, Pringle J, Porter JB (2012) Prospective study of histomorphometry, biochemical bone markers and bone densitometric response to pamidronate in beta-thalassaemia presenting with osteopenia–osteoporosis syndrome. Br J Haematol 159:462–471

    Article  CAS  PubMed  Google Scholar 

  2. Haidar R, Musallam KM, Taher AT (2011) Bone disease and skeletal complications in patients with beta thalassemia major. Bone 48:425–432

    Article  PubMed  Google Scholar 

  3. Mylona M, Leotsinides M, Alexandrides T, Zoumbos N, Dimopoulos PA (2005) Comparison of DXA, QCT and trabecular structure in beta-thalassaemia. Eur J Haematol 74:430–437

    Article  PubMed  Google Scholar 

  4. Ulivieri FM, Silva BC, Sardanelli F, Hans D, Bilezikian JP, Caudarella R (2014) Utility of the trabecular bone score (TBS) in secondary osteoporosis. Endocrine (in press)

  5. Hans D, Barthe N, Boutroy S, Pothuaud L, Winzenrieth R, Krieg MA (2011) Correlations between trabecular bone score, measured using anteroposterior dual-energy X-ray absorptiometry acquisition, and 3-dimensional parameters of bone microarchitecture: an experimental study on human cadaver vertebrae. J Clin Densitom 14:302–312

    Article  PubMed  Google Scholar 

  6. Rabier B, Heraud A, Grand-Lenoir C, Winzenrieth R, Hans D (2010) A multicentre, retrospective case–control study assessing the role of trabecular bone score (TBS) in menopausal Caucasian women with low areal bone mineral density (BMDa): analysing the odds of vertebral fracture. Bone 46:176–181

    Article  PubMed  Google Scholar 

  7. Pothuaud L, Barthe N, Krieg MA, Mehsen N, Carceller P, Hans D (2009) Evaluation of the potential use of trabecular bone score to complement bone mineral density in the diagnosis of osteoporosis: a preliminary spine BMD-matched, case–control study. J Clin Densitom 12:170–176

    Article  PubMed  Google Scholar 

  8. Pothuaud L, Carceller P, Hans D (2008) Correlations between grey-level variations in 2D projection images (TBS) and 3D microarchitecture: applications in the study of human trabecular bone microarchitecture. Bone 42:775–787

    Article  PubMed  Google Scholar 

  9. Silva BC, Leslie WD, Resch H, Lamy O, Lesnyak O, Binkley N, McCloskey EV, Kanis JA, Bilezikian JP (2014) Trabecular bone score: a non-invasive analytical method based upon the DXA image. J Bone Miner Res 29:518–530

    Article  PubMed  Google Scholar 

  10. Wood JC, Enriquez C, Ghugre N, Tyzka JM et al (2005) MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle-cells disease patients. Blood 106:1460–1465

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Angastiniotis M, Eleftheriou A (2008) Thalassaemic bone disease. An overview. Pediatr Endocrinol Rev 6(Suppl 1):73–80

    PubMed  Google Scholar 

  12. Toumba M, Skordis N (2010) Osteoporosis syndrome in thalassaemia major: an overview. J Osteoporos 2010:537673

    Article  PubMed Central  PubMed  Google Scholar 

  13. Baldini M, Forti S, Orsatti A, Ulivieri FM, Airaghi L, Zanaboni L, Cappellini MD (2011) Bone disease in adult patients with beta-thalassaemia major: a case–control study. Intern Emerg Med 9:59–63

    Article  PubMed  Google Scholar 

  14. Baldini M, Forti S, Marcon A, Ulivieri FM, Orsatti A, Tampieri B, Airaghi L, Zanaboni L, Cappellini MD (2010) Endocrine and bone disease in appropriately treated adult patients with beta-thalassemia major. Ann Hematol 89:1207–1213

    Article  CAS  PubMed  Google Scholar 

  15. Chatterjee R, Katz M, Bajoria R (2011) Use of hormone replacement therapy for correction of high turnover bone disease in hypogonadal beta-thalassemia major patients presenting with osteoporosis: comparison with idiopathic premature ovarian failure. Hemoglobin 35:653–658

    Article  CAS  PubMed  Google Scholar 

  16. Hans D, Goertzen AL, Krieg MA, Leslie WD (2011) Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: the Manitoba study. J Bone Miner Res 26:2762–2769

    Article  PubMed  Google Scholar 

  17. Origa R, Fiumana E, Gamberini MR, Armari S, Mottes M, Sangalli A, Paglietti E, Galanello R, Borgna-Pignatti C (2005) Osteoporosis in beta-thalassemia: clinical and genetic aspects. Ann N Y Acad Sci 1054:451–456

    Article  CAS  PubMed  Google Scholar 

  18. Gaudio A, Morabito N, Xourafa A, Macri I, Meo A, Morgante S, Trifiletti A, Lasco A, Frisina N (2008) Bisphosphonates in the treatment of thalassemia-associated osteoporosis. J Endocrinol Invest 31:181–184

    Article  CAS  PubMed  Google Scholar 

  19. Skordis N, Toumba M (2011) Bone disease in thalassaemia major: recent advances in pathogenesis and clinical aspects. Pediatr Endocrinol Rev 8(Suppl 2):300–306

    PubMed  Google Scholar 

  20. Leslie WD, Krieg MA, Hans D, Manitoba Bone Density Program (2013) Clinical factors associated with trabecular bone score. J Clin Densitom 16:374–379

    Article  PubMed  Google Scholar 

  21. Boutroy S, Hans D, Sornay-Rendu E, Vilayphiou N, Winzenrieth R, Chapurlat R (2013) Trabecular bone score improves fracture risk prediction in non-osteoporotic women: the OFELY study. Osteoporos Int 24:77–85

    Article  CAS  PubMed  Google Scholar 

  22. Breban S, Briot K, Kolta S, Paternotte S, Ghazi M, Fechtenbaum J, Roux C (2012) Identification of rheumatoid arthritis patients with vertebral fractures using bone mineral density and trabecular bone score. J Clin Densitom 15:260–266

    Article  PubMed  Google Scholar 

Download references

Conflict of Interest

Didier Hans is co-owner of the TBS patent and has corresponding ownership shares in Medimaps group. Marina Baldini, Fabio Massimo Ulivieri, Stella Forti, Serena Serafino, Sonia Seghezzi, Alessia Marcon, Federico Giarda, Carmelo Messina, Elena Cassinerio, Bérengère Aubry-Rozier, and Maria Domenica Cappellini declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

All procedures performed were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study (retrospective) formal consent is not required.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Baldini.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Baldini, M., Ulivieri, F.M., Forti, S. et al. Spine Bone Texture Assessed by Trabecular Bone Score (TBS) to Evaluate Bone Health in Thalassemia Major. Calcif Tissue Int 95, 540–546 (2014). https://doi.org/10.1007/s00223-014-9919-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00223-014-9919-7

Keywords

Navigation